Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3ZBio is an innovative nutraceutical and diagnostics company headquartered in Canada, with regional offices in Dubai, UAE, and Karachi, Pakistan. The company specializes in providing advanced, science-backed health solutions, notably distributing ProGsterol, the world's first synthetic peptide-based dietary supplement approved by the US FDA as a New Dietary Ingredient (NDI) to manage blood glucose levels and reverse insulin resistance. Additionally, 3ZBio offers a comprehensive portfolio of diagnostic testing kits, including the Acuteck MultiFlex 6-in-1 Health Monitor and rapid tests for infectious diseases like Dengue, Malaria, and Typhoid. By integrating biotechnology with patient-centric care, 3ZBio aims to empower individuals to manage chronic metabolic conditions and monitor their health conveniently from home.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3ZBio.